Leica Biosystems Launches Aperio ePathAccess, Powered by Dell – A Secure and Scalable Pathology Collaboration in North America
VISTA, CA – May 15, 2014 — Leica Biosystems, a global leader in anatomic pathology workflow solutions and automation, announced the launch of Aperio ePathAccess, a cloud-based software solution powered by Dell’s Unified Clinical Archive (UCA) for secure pathology collaboration. Aperio ePathAccess provides direct access to sub-specialty pathologists for secondary case review, allowing 94% faster access to slides and 24/7 security through the UCA solution.
“By deploying Aperio ePathAccess, healthcare institutions can significantly lessen the time and cost of regular shipping methods for external collaboration. Studies have shown a 76% faster turn-around-time using our technology over traditional secondary case review,” said Stephen White, vice president, corporate development, Leica Biosystems, Pathology Imaging. “The expert pathologist also experiences a gain in workflow efficiency by utilizing their time more effectively.”
“Dell and Leica Biosystems are breaking new ground in healthcare by using a secure cloud platform to connect pathologists throughout the U.S. and, ultimately, to improve the quality of care patients receive,” said Sid Nair, vice president and general manager, Healthcare and Life Sciences, Dell Services.
For more information on how Leica Biosystems, Dell, and world-leading healthcare institutions, such as Johns Hopkins, Cleveland Clinic and the University of Pennsylvania are transforming the practice of pathology, click here for a short video. To see a full list of the collaborating institutions available through Aperio ePathAccess, visit http://www.leicabiosystems.com/AperioePathAccess.
About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. Leica Biosystems provides anatomic pathology laboratories and researchers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Further information can be found at: www.LeicaBiosystems.com.
